1. Embracing Obesity in Collaboration -- Why, When, and How to Intervene

3. Introduction/Overview

4. Obesity as a Risk Factor for a Number of Disease States and Risk Factors

5. Obesity Is an Important Contributor to Progression of Osteoarthritis: Knee OA

6. Weight Loss With Liraglutide in Patients With Obesity and Mood Disorders

7. Life Expectancy Decreases as BMI Increases

8. Location of Excess Body Fat May Have a Larger Impact on Metabolic Health Than Fat Quantity

9. EASO Guidelines for Obesity Management in Primary Care

10. The Conversation: Why Do You Eat?

11. Reciprocal Signaling Between Cancer-Associated Adipocytes and Cancer Cells

12. Avoid Stigmatization of the Patient With Obesity

13. Weight Loss Improves Obesity-Related CV Comorbidities

14. Obesity: Imbalance of Energy Regulation, Not a Failure of Willpower

15. Pooled Estimates Of Incidence Depression Leading To Obesity, Relative And Absolute Risk

16. The "5 A's" of Obesity Counseling in Canadian Primary Care

17. Trust and Perceived Negative Judgment: Primary Care Physicians

18. Chronic Care Management of Patients With Obesity: the Multidisciplinary Team

19. Available Weight Loss Agents

20. Orlistat-Induced Weight Loss and Maintenance at 1 Year

21. SCALE Maintenance (Liraglutide 3
SCALE Maintenance (Liraglutide 3.0 mg): Proportion of Patients Maintaining Run-In Weight Loss or Regaining ≥ 5% From Randomization to Week 56

22. Naltrexone + Bupropion vs Placebo: Results From The COR-I Trial

23. Bariatric Surgery Is Associated With Sustained Weight Loss Over 15 Years

24. Anemia and Nutritional Deficiencies Associated With Roux-en-Y Bariatric Surgery

25. Summary and Conclusions

26. Abbreviations